Published in Am J Public Health on September 01, 2000
The risk of bias from omitted research. BMJ (2000) 1.43
Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med (1992) 12.89
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med (1995) 11.08
Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials. BMJ (1997) 6.32
Postmenopausal hormone therapy and mortality. N Engl J Med (1997) 4.96
Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet (1993) 3.56
Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med (1991) 3.53
Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med (1996) 3.35
Prior to use of estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol (1996) 3.18
Patient-specific decisions about hormone replacement therapy in postmenopausal women. JAMA (1997) 3.18
Estrogen and coronary heart disease in women. JAMA (1991) 3.17
The primary prevention of myocardial infarction. N Engl J Med (1992) 2.63
Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased? BMJ (1994) 2.54
17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation (1995) 2.49
Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol (1995) 2.30
HRT: an analysis of benefits, risks and costs. Br Med Bull (1992) 2.11
Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy. Am J Epidemiol (1989) 2.07
Hormone replacement therapy and heart disease prevention: experimentation trumps observation. JAMA (1998) 1.98
Estimating the completeness of prevalence based on cancer registry data. Stat Med (1997) 1.88
Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort. Int J Cancer (1996) 1.66
Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States. Cancer Causes Control (1996) 1.58
Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation (1994) 1.41
The waning effect of postmenopausal estrogen therapy on osteoporosis. N Engl J Med (1993) 1.27
Timing of postmenopausal estrogen for optimal bone mineral density. The Rancho Bernardo Study. JAMA (1997) 1.21
Prognostic characteristics in breast cancers after hormone replacement therapy. Breast Cancer Res Treat (1996) 1.16
Estrogen replacement therapy and breast cancer survival in a large screening study. J Natl Cancer Inst (1999) 1.08
Age, period, cohort and early mortality: an analysis of adult mortality in Italy. Popul Stud (Camb) (1989) 1.02
A review of the association of estrogens and progestins with cardiovascular disease in postmenopausal women. Arch Intern Med (1993) 0.95
The relationship between breast cancer survival and prior postmenopausal estrogen use. Obstet Gynecol (1992) 0.92
Invited commentary: can selection bias explain the cardiovascular benefits of estrogen replacement therapy? Am J Epidemiol (1996) 0.87
Hormone replacement therapy and breast cancer mortality in Swedish women: results after adjustment for 'healthy drug-user' effect. Cancer Causes Control (1993) 0.85
Hormone replacement therapy and risk of non-fatal stroke. Lancet (1997) 0.85
Impact of postmenopausal hormone therapy on cardiovascular events and cancer. Search for studies was limited. BMJ (1997) 0.84
Use of hormone replacement therapy. Hormone replacement therapy may not always be right choice to prevent cardiovascular disease. BMJ (1996) 0.77
Impact of postmenopausal hormone therapy on cardiovascular events and cancer. Inclusion of one particular study was inappropriate. BMJ (1997) 0.77
Hormone replacement therapy and early clinical appearance of low grade breast cancer. Cancer Causes Control (1997) 0.76
Impact of postmenopausal hormone therapy on cardiovascular events and cancer. Study's conclusions were incorrect. BMJ (1997) 0.76
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst (2003) 6.20
EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. Ann Oncol (2003) 5.78
Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut (2001) 4.22
Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut (2000) 4.02
Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest (2000) 3.96
EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol (2003) 3.88
Periodontal disease and risk of cerebrovascular disease: the first national health and nutrition examination survey and its follow-up study. Arch Intern Med (2000) 3.82
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Identification of periodontal pathogens in atheromatous plaques. J Periodontol (2000) 3.45
Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres. Int J Epidemiol (1997) 3.39
Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer (2005) 3.04
Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol (2001) 2.97
Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy. Diabetologia (2010) 2.91
Survival of colorectal cancer patients in Europe during the period 1978-1989. EUROCARE Working Group. Eur J Cancer (1998) 2.74
Examination of the relation between periodontal health status and cardiovascular risk factors: serum total and high density lipoprotein cholesterol, C-reactive protein, and plasma fibrinogen. Am J Epidemiol (2000) 2.64
Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes. Diabetologia (2006) 2.53
XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis (2001) 2.35
Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer (2011) 2.20
Uric acid metabolism and tubular sodium handling. Results from a population-based study. JAMA (1993) 2.10
Epidemiology of gallstone disease in Italy: prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.) Am J Epidemiol (1995) 2.09
Patterns of lung cancer risk according to type of cigarette smoked. Int J Cancer (1984) 2.07
Variations in survival from breast cancer in Europe by age and country, 1978-1989. EUROCARE Working Group. Eur J Cancer (1998) 2.04
High endogenous estradiol is associated with increased venous distensibility and clinical evidence of varicose veins in menopausal women. J Vasc Surg (2000) 2.03
Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology (2000) 1.86
Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe. Eur J Cancer (2011) 1.84
Mixture models for cancer survival analysis: application to population-based data with covariates. Stat Med (1999) 1.82
TBARS and cardiovascular disease in a population-based sample. J Cardiovasc Risk (2001) 1.81
Triazine herbicides and ovarian epithelial neoplasms. Scand J Work Environ Health (1989) 1.81
Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology. Eur J Cancer (2003) 1.79
Variation in survival of patients with lung cancer in Europe, 1985-1989. EUROCARE Working Group. Eur J Cancer (1998) 1.77
Defects in hemopoietic stem cell activity in Ikaros mutant mice. J Exp Med (1999) 1.76
Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer (2001) 1.76
Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis. Diabetologia (2007) 1.73
Increased carotid intima-media thickness in children-adolescents, and young adults with a parental history of premature myocardial infarction. Eur Heart J (2002) 1.73
Cancer prevalence in European registry areas. Ann Oncol (2002) 1.72
Alcohol and cardiovascular disease--more than one paradox to consider. Average volume of alcohol consumption, patterns of drinking and risk of coronary heart disease--a review. J Cardiovasc Risk (2003) 1.71
Cancer of the larynx/hypopharynx, tobacco and alcohol: IARC international case-control study in Turin and Varese (Italy), Zaragoza and Navarra (Spain), Geneva (Switzerland) and Calvados (France). Int J Cancer (1988) 1.69
Serum uric acid and hypertension: the Olivetti heart study. J Hum Hypertens (1994) 1.66
Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res (1988) 1.66
Early increase of carotid intima-media thickness in children with parental history of premature myocardial infarction. Heart (2009) 1.64
Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol (2004) 1.63
Toward a comparison of survival in American and European cancer patients. Cancer (2000) 1.63
Insulin and gall stones: a population case control study in southern Italy. Gut (2000) 1.60
Correlates of compliance in a randomized exercise trial in myocardial infarction patients. Med Sci Sports Exerc (2001) 1.58
Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects. Oncogene (2012) 1.53
Absence of siblings--a risk factor for hypertension? N Engl J Med (1991) 1.53
The role of osteopenia in oral bone loss and periodontal disease. J Periodontol (1996) 1.51
Introduction: the EUROCARE II Study. Eur J Cancer (1998) 1.50
Modifying risk of developing lung cancer by changing habits of cigarette smoking. Br Med J (Clin Res Ed) (1984) 1.50
Effects of transportation and delay in processing on the stability of nutritional and metabolic biomarkers. Nutr Cancer (2000) 1.49
Osteoporosis and oral infection: independent risk factors for oral bone loss. J Dent Res (2008) 1.48
Relationship of alcohol intake and sex steroid concentrations in blood in pre- and post-menopausal women: the European Prospective Investigation into Cancer and Nutrition. Cancer Causes Control (2006) 1.47
Statistical inference for the area under the receiver operating characteristic curve in the presence of random measurement error. Am J Epidemiol (2001) 1.47
Diet in the aetiology of cancer: a review. Eur J Cancer (1994) 1.45
Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program. Int J Epidemiol (2000) 1.44
Long-term weight change and breast cancer risk: the European prospective investigation into cancer and nutrition (EPIC). Br J Cancer (2005) 1.44
Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study. Nutr Metab Cardiovasc Dis (2009) 1.43
Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol (2013) 1.43
Common genetic variation near the connexin-43 gene is associated with resting heart rate in African Americans: a genome-wide association study of 13,372 participants. Heart Rhythm (2012) 1.43
Long-term psychological effects of natural disasters. Psychosom Med (1996) 1.42
Survival of women with breast cancer in Europe: variation with age, year of diagnosis and country. The EUROCARE Working Group. Int J Cancer (1998) 1.41
IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer (2006) 1.39
Increased plasma HDL-cholesterol and apo A-I in breast cancer patients undergoing adjuvant tamoxifen therapy. Clin Biochem (2000) 1.39
Plant-based diet, serum fatty acid profile, and free radicals in postmenopausal women: the diet and androgens (DIANA) randomized trial. Int J Biol Markers (2005) 1.38
Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of Cholelithiasis. Hepatology (1997) 1.36
Dietary vitamin C and the risk for periodontal disease. J Periodontol (2000) 1.36
Plasma carotenoids as biomarkers of intake of fruits and vegetables: individual-level correlations in the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur J Clin Nutr (2005) 1.36
Variability of fish consumption within the 10 European countries participating in the European Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr (2002) 1.35
A case-control study of brain gliomas and occupational exposure to chemical carcinogens: the risk to farmers. Am J Epidemiol (1988) 1.35
Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study. Br J Cancer (2006) 1.34
A method for the estimation of chronic disease morbidity and trends from mortality data. Stat Med (1989) 1.33
Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut (2005) 1.32
Test-retest reliability of the cognitive lifetime drinking history. Am J Epidemiol (1997) 1.32
Altered renal sodium handling in men with abdominal adiposity: a link to hypertension. J Hypertens (2001) 1.28
Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer (2011) 1.27
Urinary sodium excretion and blood pressure in children: absence of a reproducible association. Hypertension (1983) 1.27
Vertebroplasty as treatment of aggressive and symptomatic vertebral hemangiomas: up to 4 years of follow-up. Neuroradiology (2009) 1.26
Patterns of alcohol consumption in 10 European countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) project. Public Health Nutr (2002) 1.26
The EUROCARE study of survival of cancer patients in Europe: aims, current status, strengths and weaknesses. Eur J Cancer (2001) 1.24
Periodontal disease and risk of coronary heart disease. JAMA (2001) 1.23
The relation of serum levels of antioxidant vitamins C and E, retinol and carotenoids with pulmonary function in the general population. Am J Respir Crit Care Med (2001) 1.22
Validity for epidemiological studies of long-term cryoconservation of steroid and protein hormones in serum and plasma. Cancer Epidemiol Biomarkers Prev (1995) 1.22
Efficacy of screening in preventing invasive cervical cancer: a case-control study in Milan, Italy. IARC Sci Publ (1986) 1.21
A randomized trial on the effect of decreased dietary sodium intake on blood pressure in adolescents. J Hypertens (1984) 1.20
Proportion of lung cancers due to occupational exposure. Int J Cancer (1984) 1.18
A prospective study of hypertension and the incidence of kidney stones in men. J Hypertens (1999) 1.17
Cancer survival in European adolescents and young adults. Eur J Cancer (2003) 1.17
Mistletoe in cancer - a systematic review on controlled clinical trials. Eur J Med Res (2003) 1.16